Bionano genomics announces launch of clia-certified bionano laboratories, and expands its clinical testing menu with launch of first ogm-based ldt for fshd

San diego, sept. 23, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced the launch of bionano laboratories, a new organization that combines bionano's optical genome mapping (ogm) data services with the clinical testing services previously offered by lineagen, and the launch of bionano laboratories' first ogm-based laboratory developed test (ldt). bionano laboratories recently received clia-certification for its lab in san diego. this certification will enable bionano laboratories to offer services to customers seeking to implement ogm into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties that may desire a more robust regulatory structure for their projects.
BNGO Ratings Summary
BNGO Quant Ranking